Live feed
Filing
SC 13G/A
SC 13G/A0000902219-21-000079·Blueprint Medicines Corp
Schedule 13G ownership disclosure
N/A
Security class unavailable · CUSIP: 09627Y109
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,036,630
- Percent of class
- 1.8600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-21-000079
- Form type
- SC 13G/A
- Filer
- Blueprint Medicines Corp
- CIK
- CIK 1597264
- Filed
- Feb 03, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership